Virtus ETF Advisers’s Urovant Sciences Ltd. UROV Stock Holding History

Virtus ETF Advisers’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,324	Closed	-$296K	–	410
2020 Q4	$296K	Buy	+18,324	New	+$227K	0.12%	219

Virtus ETF Advisers's UROV Position: Q1 2021 in Review

Virtus ETF Advisers sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 18,324 shares — an estimated $296K sold.

Virtus ETF Advisers first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $296K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Virtus ETF Advisers reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Virtus ETF Advisers sold 18,324 Urovant Sciences Ltd. shares in Q1 2021, an estimated $296K.
Virtus ETF Advisers first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Virtus ETF Advisers's Urovant Sciences Ltd. position peaked at $296K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.